Activation of proteolytic enzymes, including cysteine proteases of the ced-3͞ICE family, is a characteristic feature of the apoptotic program. In contrast, the role of the proteasome as the major nonlysosomal machinery to degrade or process proteins by ATP͞ubiquitin-dependent proteolysis in this process is less clear. In human leukemic HL60 cells, inhibition of proteasome-mediated proteolysis by specific proteasomal inhibitors leads to the rapid induction of apoptosis as judged by morphological changes as well as by nuclear condensation and DNA fragmentation. HL60 apoptosis is due to activation of CPP32, a member of the ced-3͞ICE family of cysteine proteases, and appears to occur independently from ICE activity. HL60 apoptosis is accompanied by an increase in the concentration of the cyclin-dependent kinase inhibitor p27 Kip1 . Labeling of the cells by the TUNEL technique demonstrates that HL60 cells undergoing apoptosis are primarily in the G 1 phase of the cell cycle. Proteasomal activity therefore appears to be required in proliferating, but not in quiescent, HL60 cells for cell survival as well as normal progression through the cell cycle.Apoptosis has been recognized as a distinct form of cell death that has an essential function in the regulation of cell turnover during development, tissue homeostasis, and cancer (1, 2). For a long time the characteristic cleavage of DNA into oligonucleosomal fragments has been regarded as a hallmark of apoptosis and was the only biochemical marker available. Recently the focus of interest has shifted toward proteolytic events during apoptotic cell death, and it has become apparent that activation of proteolytic enzymes, culminating in the disintegration of the cell, is a characteristic feature of apoptosis. In particular, cysteine proteases of the ced-3͞ICE family have been implicated as central components of this proteolytic machinery (3). However, in contrast to the intense research efforts spent on the ced-3͞ICE family of proteases, much less attention has been paid so far to the multicatalytic protease complex (MCP) or proteasome, which represents the cell's major nonlysosomal tool to rapidly degrade or process proteins by ATP͞ubiquitin-dependent proteolysis and its potential role in apoptotic cell death. In higher eukaryotic cells the MCP is involved in the degradation of most of the cytosolic proteins and in particular of short-lived proteins critical for cell proliferation and cell cycle regulation. Examples include the tumor suppressor protein p53 (4) and various cyclins (5), as well as the cyclin-dependent kinase inhibitor p27 Kip1 (6). The proteasome in addition has a direct impact on transcriptional regulation by processing and degradation of NF B and I B respectively, as well as by proteolysis of transcription factors such as c-Fos (7, 8) and c-Jun (9). Finally, studies performed in two developmental systems, regression of the intersegmental muscles in the hawkmoth Manduca sexta and thyroxininduced apoptosis in the tadpole tail, suggest a link between...